cancer Archives | Page 4 of 9 | Be Korea-savvy
Black Belt TX Forms a Strategic Partnership with Praxis Biotech to Develop New Therapies Targeting Stress Response Pathways in Cancer

Black Belt TX Forms a Strategic Partnership with Praxis Biotech to Develop New Therapies Targeting Stress Response Pathways in Cancer

Stevenage, UK and San Francisco, U.S., Nov. 5 (Korea Bizwire) – Black Belt TX, a company focused on targeting stress response pathways in cancer, and Praxis Biotech, a biotech company focused on the discovery of small molecules modulating cellular stress mechanisms in different disease areas, have entered into a strategic partnership to jointly discover and [...]

More Than Half of Male Cancer Patients Continue to Smoke After Initial Diagnosis

More Than Half of Male Cancer Patients Continue to Smoke After Initial Diagnosis

SEOUL, Jul. 25 (Korea Bizwire) — More than half of male smokers in South Korea continue to smoke even after being diagnosed with cancer, a recent study has revealed. A research team from the Seoul National University Bundang Hospital studied 15,000 male patients over 40 years of age who were initially diagnosed with cancer between [...]

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, Supported by Helsinn, Awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, Supported by Helsinn, Awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

Lugano, Switzerland, Jun. 1 (Korea Bizwire) – Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, in conjunction with the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO), today announces Allison Barz Leahy, MD, University of Pennsylvania, as the recipient of the Anna Braglia Endowed Young Investigator Award in [...]

Cancer Deaths Up 72 pct Over Past Ten Years

Cancer Deaths Up 72 pct Over Past Ten Years

SEOUL, May 2 (Korea Bizwire) – Cancer deaths have increased by 72 percent in the past decade, with lung cancer being most commonly diagnosed, followed by liver, stomach, pancreas, colon and breast cancer. According to the Korea Insurance Development Institute on Wednesday, the number of life insurance subscribers who died of cancer increased from 18,144 [...]

Combination of First-in-class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in vivo Models of Lung Cancer

Combination of First-in-class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in vivo Models of Lung Cancer

Paris, France; Cambridge, Massachusetts (USA); Apr. 2 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the ‘‘Company’’) a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced preclinical data from studies currently being conducted under its collaborations with The University of Texas MD Anderson Cancer Center and the Weill Cornell [...]

S. Korea Builds Memorial Park for Children Who Succumb to Cancer

S. Korea Builds Memorial Park for Children Who Succumb to Cancer

SEOUL, Feb. 13 (Korea Bizwire) — A Children’s Memorial Park, where children who pass away after suffering from cancer and leukemia can rest in peace, will be built in South Korea for the very first time. HiFamily, a South Korean protestant organization, will be opening the Andersen Memorial Park inside ‘W-Story’, a family theme park [...]

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Paris, France, Cambridge, Massachusetts (USA) and Houston, Texas (USA), Jan. 7 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers. [...]